Tweedy Browne Global Value Fund's Top Five Positions

Author's Avatar
Oct 22, 2013
Article's Main Image
Over the past quarter the Tweedy Browne Global Value Fund kept pretty quiet, buying only two new stocks. The global fund currently holds 102 stocks valued at approximately $5.695 billion. This global fund primarily seeks non-U.S. marketable equity securities in developed markets where practicable, perceived foreign currency exposure is hedged back into the U.S. dollar.

The following five companies represent the top five stock holdings of the Tweedy Browne Global Value Fund.

Roche Holding AG (XSWX:ROG)

Tweedy Browne Global’s largest position is in the Swiss company Roche Holding. The fund holds on to a total of 984,000 shares, representing 0.11% of the company’s shares outstanding and 4.7% of their total portfolio.

The fund has not altered their position in Roche Holdings since 2010Q4. Since their initial buy in 2008, the fund has seen average gains of about 59%.

Tweedy Browne’s historical holding history:

1382473792030.png

Roche Holding AG manufactures and develops pharmaceutical product. It produces drugs for cardiovascular, infectious, dermatology, autoimmune, and respiratory diseases. Roche Holding’s headquarters are located in Basel, Switzerland.

Roche Holding’s historical revenue and net income:

1382475010839.png

The analysis on the company reports that the revenue has been in decline over the past five years, the operating margin is expanding and that the price is sitting near a 5-year high.

The Peter Lynch Chart suggests that Roche is currently overvalued:

1382475040953.png

Roche Holding AG has a market cap of CHF209.69 billion. Its shares are currently trading at around CHF243.10 with a P/E ratio of 21.80, a P/S ratio of 4.51 and a P/B ratio of 12.54. The company had an annual average earnings growth of 11.1% over the past ten years.

Total SA (XPAR:FP)

Tweedy Browne’s second largest position is in Total SA where they hold on to 4,520,000 shares of the company’s stock. The fund’s position in Total SA represents 4.6% of their total portfolio and 0.20% of the company’s shares outstanding.

The fund has not changed their holdings in Total since the first quarter of 2013. Since their primary buy in 2009, the fund has seen average gains of 15%.

Tweedy Browne’s holding history as of the third quarter:

1382474034736.png

Total SA is an international oil and gas company in the world. With operations in more than 130 countries, the Company engages in all aspects of the petroleum industry, including upstream operations and downstream operations.

Total SA’s historical revenue and net income:

1382475318823.png

The Peter Lynch Chart shows that Total SA is currently undervalued:

1382475344195.png

Total SA has a market cap of €100.7 billion. Its shares are currently trading at around $44.40 with a P/E ratio of 10.60, a P/S ratio of 0.57 and a P/B ratio of 1.39. Total SA currently holds a 5.32% dividend yield. The company had an annual average earnings growth of 5.00% over the past ten years.

Novartis AG (XSWX:NOVN)

Tweedy Browne’s third largest holding is in Novartis where they hold on to 3,002,000 shares of the company’s stock. This holding makes up for 4.1% of Tweedy Browne’s total portfolio and for 0.12% of the company’s shares outstanding.

The fund has not altered their position in Novartis since 2012Q1. Since their first buy in 2009, the fund has seen average annual gains of 36%.

Tweedy Browne’s historical holding history:

1382474183600.png

Novartis provides healthcare solutions that address the evolving needs of patients and societies worldwide with a portfolio that includes innovative medicines, preventive vaccines and diagnostic tools, generic pharmaceuticals and consumer health products. Novartis is a Switzerland-based company.

Novartis’ historical revenue and net income:

1382475680932.png

The analysis on Novartis reports that the company’s operating margin is expanding, the price is close to a 10-year high, the dividend yield is at a 5-year low and that the revenue has slowed down in the past year.

The Peter Lynch Chart suggests that the company is currently overvalued:

1382475705360.png

Novartis has a market cap of CHF166.15 billion. Its shares are currently trading at around CHF67.90 with a P/E ratio of 19.70, a P/S ratio of 3.19 and a P/B ratio of 2.64. The company had an annual average earnings growth of 8.20% over the past ten years.

1382474398471.png

Axel Springer AG publishes prints and distributes newspapers and magazines. Its purchased services include printing services, direct marketing, editorial services, and circulation and insurance services. It also produces television and radio programming.

Axel Springer’s historical revenue and net income:

1382475964835.png

The Peter Lynch Chart suggests that the company is currently overvalued:

1382476007755.png

Axel Springer AG has a market cap of €4.45 billion. Its shares are currently trading at around €45.06 with a P/E ratio of 19.00, a P/S ratio of 1.34 and a P/B ratio of 1.91. The company had an annual average earnings growth of 27.90% over the past ten years.

Royal Dutch Shell PLC (XAMS:RDSA)

The fund’s fifth largest position goes to Royal Dutch Shell where they hold on to 6,051,190 shares. This position makes up for 3.5% of their total portfolio and 0.10% of the company’s shares outstanding.

The company added nearly 80,000 shares during the second quarter, but did not make any changes over the duration of the past quarter. Since the fund bought into Royal Dutch, they have seen average losses of -8%.

Tweedy Browne’s historical holding history:

1382474566924.png

Royal Dutch Shell is an integrated oil and gas company. The company’s operating segment consists of Upstream, Downstream and Projects & Technology. Royal Dutch Shell is currently traded in the U.K., the Netherlands, the U.S. and Germany. Royal Dutch Shell is headquartered and based out of The Hague, Netherlands.

Royal Dutch Shell’s historical revenue and net income:

1382476179585.png

The analysis on the company reports that the company’s revenue has been in decline over the past year, the price is nearing a one-year high, the operating margin is expanding and the dividend yield is at a 1-year high.

The Peter Lynch Chart suggests that the company is currently undervalued:

1382476200885.png

Royal Dutch Shell has a market cap of €156.19 billion. Its shares are currently trading at around €24.56 with a P/E ratio of 8.70, a P/S ratio of 0.45 and a P/B ratio of 1.17. The company had an annual average earnings growth of 1.9% over the past ten years.

Check out Tweedy Browne Global Value Fund’s complete third quarter portfolio here.

Try a free 7-day premium membership.